CAS 2163056-91-3

2-(4-(4-(Isoquinolin-4-yl)phenyl)-1H-pyrazol-1-yl)-N,N-dimethylacetamide

CAS : 2163056-91-3

Formule : C₂₂H₂₀N₄O

Degré de pureté : %

Couleur et forme : Solid

Masse moléculaire : 356.4204

Ref: IN-DA01K8N6

BI-1347

CAS : 2163056-91-3

BI-1347

Degré de pureté : ≥95%

Masse moléculaire : 356.42g/mol

Ref: 54-BUP08987

BI-1347

CAS : 2163056-91-3

BI-1347 is a potent, selective inhibitor of CDK8/cyclinC (IC50: 1 nM). It shows tumor growth inhibition in an in vivo xenograft model.

Formule : C₂₂H₂₀N₄O

Degré de pureté : 96.7% - 99.63%

Couleur et forme : Solid

Masse moléculaire : 356.42

Ref: TM-T5405

BI-1347

CAS : 2163056-91-3

Degré de pureté : 99+%

Masse moléculaire : 356.164

Ref: 10-F799352

BI-1347

CAS : 2163056-91-3

BI-1347 is a small molecule that has been shown to be effective in the treatment of leukemia cells and bowel disease. It is a potent inhibitor of the intracellular protein tyrosine phosphatase, which regulates the activation of various growth factors. BI-1347 has also been shown to stimulate epidermal growth factor receptor (EGFR) signaling, leading to increased epidermal growth. This drug has also been shown to have anti-inflammatory properties in animal models for inflammatory bowel disease by inhibiting cytokines that promote inflammation. BI-1347 may be used for cancer prevention or treatment as it inhibits tumor cell proliferation and induces apoptosis.

Formule : C₂₂H₂₀N₄O

Degré de pureté : Min. 95%

Masse moléculaire : 356.42 g/mol

Ref: 3D-NLD05691